Retrovirus from the hiv group and its use
CA 2107732 C · Owner: Eberle, Josef · Inventors: Hauser, Hans-Peter; Gurtler, Lutz G.; Knapp, Stefan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immuno- deficiency diseases are also disclosed as are the DNA and amino acid sequences of the virus.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 5, 1993 and granted April 8, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 5, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 5, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.